---
schema_version: "secwatch.filing_event.v1"
accession: "0001778922-26-000049"
form_type: "8-K"
ticker: "SGP"
cik: "0001778922"
company_name: "SpyGlass Pharma, Inc."
filed_at: "2026-10-01T12:15:18+00:00"
generated_at: "2026-10-12T14:16:34.552974+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.82
calibrated_materiality_score: 0.82
confidence: "high"
source: SEC EDGAR
---

# SpyGlass Pharma acquires AVS from Santen for $13M to secure IOL supply

## Summary
- SpyGlass Pharma closed its acquisition of 100% of Advanced Vision Science (AVS) from Santen Holdings US on October 1, 2026, for a purchase price of $13,000,000 in cash.
- AVS was SpyGlass Pharma's intraocular lens supplier and will continue to manufacture IOLs under the Eternity brand for Santen, which gets exclusive rights to sell those products in Japan.
- At closing, AVS and Santen Pharmaceutical Co., Ltd. signed an Amended and Restated Supply and Distribution Agreement and cross licenses.
- AVS will continue licensing its glistening-free hydrophobic acrylic lens material to Bausch + Lomb for the enVista IOL line and manufacturing for other global IOL companies.
- SpyGlass said the deal secures scalable commercial IOL manufacturing for its Phase 3 BIM-IOL System and may add toric and extended depth-of-focus premium lenses.

## SEC filing metadata
- accession: 0001778922-26-000049
- form_type: 8-K
- ticker: SGP
- cik: 0001778922
- company_name: SpyGlass Pharma, Inc.
- filed_at: 2026-10-01T12:15:18+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.82
- calibrated_materiality_score: 0.82
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1778922/000177892226000049/0001778922-26-000049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1778922/000177892226000049/sgp-20261001.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001778922-26-000049
- JSON: https://secwatch.observer/filing/0001778922-26-000049.json
- Plain text: https://secwatch.observer/filing/0001778922-26-000049.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.